118 results
Page 2 of 6
8-K
EX-99.1
v0d kqpts0y49
7 Nov 22
Agile Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
424B5
mmwhcadcxayi2cxen7i0
23 Aug 22
Prospectus supplement for primary offering
4:30pm
8-K
EX-99.1
gfxd087muobnhf
11 Aug 22
Agile Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
424B4
kdndhj4crs eoh37qr
5 Jul 22
Prospectus supplement with pricing info
4:26pm
8-K
1qg2vz8mfi72al2
24 May 22
Departure of Directors or Certain Officers
7:30am
8-K
EX-99.1
4hkcx4ern16 35
12 May 22
Agile Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
424B5
1fci9fanta 0w
27 Apr 22
Prospectus supplement for primary offering
6:30am
8-K
EX-99.1
b57u3118jsx
30 Mar 22
Agile Therapeutics Reports Fourth Quarter & Full Year 2021 Financial Results and Provides Corporate Update
4:19pm
424B5
zun542fvn9cq463i 06
14 Mar 22
Prospectus supplement for primary offering
5:26pm
8-K
xhlt3 ic2glol
10 Jan 22
Entry into a Material Definitive Agreement
8:05am
424B5
vmzzaujrkt5gtnxxi
10 Jan 22
Prospectus supplement for primary offering
8:00am